Activist investor claims Pfizer coerced former execs amid power struggle
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard Value.
Pfizer Stock Soars as Activist Investor Starboard Takes $1 Billion Stake
Pfizer's (PFE, Financial) stock experienced a boost on Monday, surging by 3 %, following the news that activist investor Starboard Value has acquired a substantial stake in the pharmaceutical giant. The investment,
Pfizer's CEO gains support of ex-execs amid activist investor talks
"We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer Chairman & CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value," the two wrote, in a statement issued on behalf of them by Guggenheim Securities.
Ex-Pfizer leaders side with firm against activist investor
Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a brief statement saying they are "fully supportive of Pfizer chairman and CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value."
Pfizer’s Leadership Stability and Activist Investor Watch: A Hold Rating Analysis
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer (PFE -2.82%) that's worth approximately $1 billion. Now, Starboard
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value.The ex-Pfizer executives, Ian Read and Frank D'Amelio,
How activist Irenic can amicably build shareholder value at Reservoir Media
Irenic Capital isn't seeking a confrontational approach at Reservoir. In fact, the activist may be a good partner for the ...
Activist investors: power players or catalysts for long-term value?
Be it Disney or Starbucks, activist investors are targetting companies at an unprecedented rate, boosting short-term returns ...
Activist Investors’ Strategy Demands See US CEOs Depart Quicker
Chief executive officers in the US are heading for the exits faster in battles with activist investors, according to a report ...
Major CVS shareholder plans activist push, will meet with management, sources say
Glenview Capital is expected to meet with CVS management on Monday to discuss its plans for value creation at the struggling ...
Spotify11d
Reservoir Media faces activist investor call for ‘strategic review to maximize shareholder value’
Adam McCullough/Shutterstock Reservoir recently announced a deal to represent the publishing catalog of Snoop Dogg (pictured) ...
Pfizer ex-CEO and CFO exit Starboard activist campaign
Pfizer (PFE) stock slips as former executives Ian Read and Frank D'Amelio exit Starboard Value's activist campaign against ...
Major CVS Shareholder To Push For Operational Improvements In Meeting With Top Execs: Reports
CNBC reported that Glenview Capital, a hedge fund, has firmly established a sizeable stake in the company. However, CVS is ...
Former Pfizer Executives Ian Read And Frank D'Amelio Support Albert Bourla's Leadership Amid Starboard Activism: 'Will Deliver Shareholder Value'
CEO Ian Read and ex-CFO Frank D’Amelio have decided to distance themselves from the activist campaign led by Starboard Value ...